498050·Stock-Sector-Healthcare
HANARO Bio Korea Active
Introduction
The HANARO Bio Korea Active ETF aims to outperform the iSelect K-Bio Healthcare index by actively adjusting weightings and selectively including non-benchmark asset in its portfolio
Investment Points
An ETF that primarily invests in Korean pharmaceutical, biotech, and healthcare companies with global market competitiveness in areas such as biosimilars, CDMO (Contract Development and Manufacturing Organization), medical devices, and diagnostic technologies, based on quantitative and qualitative research.
Benchmark Index
iSelect K-Bio Healthcare index
Benchmark Index Description
An index composed of Korean companies engaged in pharmaceuticals/biotech, medical devices, and healthcare-related businesses.
Issuer
NH-Amundi Asset Management Co., Ltd.
Brand
HANARO
Total Fee
0.5
Listing Date
2024-11-26
International Securities Code
KR7498050004
Market Information
Market Capitalization
15,356,250,000KRW
Transaction Amount
111,187,335KRW
Trading Volume
7,577
Shares Outstanding
1,050,000
NAV
14,664
52-Week High
18,015KRW
52-Week Low
9,705KRW